Guardant Health 2024年第四季度调整后每股收益$(0.62)优于预期$(0.74),销售额为$201.814M超出预期$192.141M

财报速递2025-02-21
Guardant Health (NASDAQ:GH) 报告季度每股亏损$(0.62),这比分析师一致预期的每股亏损$(0.74)高出16.22%。与去年同期每股亏损$(0.64)相比增长3.13%。公司报告季度销售额为$201.814M,比分析师一致预期的$192.141M超出5.03%。与去年同期销售额$155.054M相比增长30.16%。

以上内容来自Benzinga Earnings专栏,原文如下:

Guardant Health (NASDAQ:GH) reported quarterly losses of $(0.62) per share which beat the analyst consensus estimate of $(0.74) by 16.22 percent. This is a 3.13 percent increase over losses of $(0.64) per share from the same period last year. The company reported quarterly sales of $201.814 million which beat the analyst consensus estimate of $192.141 million by 5.03 percent. This is a 30.16 percent increase over sales of $155.054 million the same period last year.

免责声明:本文观点仅代表作者个人观点,不构成本平台的投资建议,本平台不对文章信息准确性、完整性和及时性做出任何保证,亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白
发表看法